Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AMGN | GILD | VRTX | REGN |
| Company | Adaptimmune Ther ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.9676 | 265.64 | 67.01 | 394.19 | 901.26 |
| High | 0.9893 | 265.92 | 67.02 | 396.14 | 908.81 |
| Low | 0.8721 | 262.58 | 65.90 | 391.01 | 891.67 |
| Last | 0.8984 | 262.75 | 66.16 | 393.48 | 893.99 |
| Change | -0.0886 | -1.32 | -0.77 | +0.38 | -7.20 |
| % Change | -8.98% | -0.50% | -1.15% | +0.10% | -0.80% |
| Volume | 3,345,600 | 2,082,700 | 6,442,200 | 949,000 | 450,600 |
| 20-Day Average Volume | 1,394,035 | 2,201,900 | 6,214,910 | 909,480 | 434,065 |
| Previous Close | 0.9870 | 264.07 | 66.93 | 393.10 | 901.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3143 | 272.96 | 70.21 | 406.59 | 938.74 |
| 20-Day Raw Stochastic | 3.38% | 0.65% | 3.10% | 8.11% | 4.01% |
| 20-Day Relative Strength | 33.23% | 36.64% | 27.91% | 36.90% | 33.38% |
| Weighted Alpha | -56.68 | +4.25 | -25.27 | +15.62 | +11.94 |
| Today's Opinion | 8% Buy | 56% Sell | 100% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 24% Buy | 56% Sell | 100% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 80% Buy | 8% Sell | 88% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -30.36% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -1.69% since 04/11/24 | -2.86% since 04/11/24 |
| Low | 0.8721 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.2799 on 04/12/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 402.49 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -38.88% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -4.35% since 03/18/24 | -6.87% since 03/18/24 |
| Low | 0.8721 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.6500 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +24.35% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | -9.12% since 01/18/24 | -3.87% since 01/18/24 |
| Low | 0.6900 on 01/19/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.0500 on 03/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +53.10% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | +7.05% since 10/18/23 | +8.23% since 10/18/23 |
| Low | 0.4200 on 11/28/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 2.0500 on 03/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 981,288 | 141,520,144 | 83,333,008 | 101,600,240 | 98,916,416 |
| Shares Outstanding, K | 994,213 | 535,919 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 60,280,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -113,870,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 230,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -47,920,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 2.39 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 03/06/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 10.02 | 29.33 | 23.79 |